Pharmacology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmacology stocks.

Pharmacology Stocks Recent News

Date Stock Title
May 1 JNJ Janssen adopts J&J name as part of global rebranding effort
May 1 JNJ J&J Seeks Backing for $11 Billion Baby Powder Cancer Deal
May 1 JNJ Update: Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims
May 1 ARCT Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
May 1 AMPH Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
May 1 JNJ Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
May 1 JNJ UPDATE 1-J&J advances $6.48 billion settlement of talc cancer lawsuits
May 1 JNJ J&J's proposed $6B+ talc settlement negatively impacts some Q1 results
May 1 JNJ J&J seeks over $6B settlement to resolve talc-related cancer claims
May 1 JNJ J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
May 1 JNJ J&J advances $6.48 billion settlement of talc cancer lawsuits
May 1 JNJ J&J advances $6.475 billion settlement of talc cancer lawsuits
May 1 JNJ Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual "Prepackaged" Reorganization
May 1 JNJ Johnson & Johnson Has a New Plan to Settle Talc Bankruptcy
May 1 JNJ 3 No-Brainer Stocks to Buy With $200 Right Now
Apr 30 ICLR ICON announces pricing of $2B notes
Apr 30 ICLR ICON Announces Pricing of USD 2 Billion Notes
Apr 30 AMPH Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
Apr 30 ICLR ICON Public Limited Company (NASDAQ:ICLR) Q1 2024 Earnings Call Transcript
Apr 30 AMPH Why Amphastar (AMPH) Could Beat Earnings Estimates Again
Pharmacology

Pharmacology is the branch of biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within the body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities. The two main areas of pharmacology are pharmacodynamics and pharmacokinetics. Pharmacodynamics studies the effects of a drug on biological systems, and Pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological receptors, and pharmacokinetics discusses the absorption, distribution, metabolism, and excretion (ADME) of chemicals from the biological systems. Pharmacology is not synonymous with pharmacy and the two terms are frequently confused. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is concerned with application of the principles learned from pharmacology in its clinical settings; whether it be in a dispensing or clinical care role. In either field, the primary contrast between the two are their distinctions between direct-patient care, for pharmacy practice, and the science-oriented research field, driven by pharmacology.
The origins of clinical pharmacology date back to the Middle Ages in Avicenna's The Canon of Medicine, Peter of Spain's Commentary on Isaac, and John of St Amand's Commentary on the Antedotary of Nicholas. Clinical pharmacology owes much of its foundation to the work of William Withering. Pharmacology as a scientific discipline did not further advance until the mid-19th century amid the great biomedical resurgence of that period. Before the second half of the nineteenth century, the remarkable potency and specificity of the actions of drugs such as morphine, quinine and digitalis were explained vaguely and with reference to extraordinary chemical powers and affinities to certain organs or tissues. The first pharmacology department was set up by Rudolf Buchheim in 1847, in recognition of the need to understand how therapeutic drugs and poisons produced their effects.Early pharmacologists focused on natural substances, mainly plant extracts. Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts. Today pharmacologists use genetics, molecular biology, biochemistry, and other advanced tools to transform information about molecular mechanisms and targets into therapies directed against disease, defects or pathogens, and create methods for preventative care, diagnostics, and ultimately personalized medicine.

Browse All Tags